Repligen Corp (NASDAQ:RGEN)

185.13
Delayed Data
As of 4:00pm ET
 -4.64 / -2.45%
Today’s Change
162.29
Today|||52-Week Range
327.32
-30.10%
Year-to-Date

Today’s Trading

Previous close189.77
Today’s open186.78
Day’s range180.35 - 189.19
Volume29,233
Average volume (3 months)442,609
Market cap$10.2B
Data as of 4:00pm ET, 01/25/2022

Growth & Valuation

Earnings growth (last year)+157.46%
Earnings growth (this year)-97.58%
Earnings growth (next 5 years)+28.50%
Revenue growth (last year)+35.53%
P/E ratio88.2
Price/Sales28.20
Price/Book6.60

Competitors

 Today’s
change
Today’s
% change
RDYDr Reddy's Laborator...+0.18+0.31%
UTHRUnited Therapeutics ...-2.88-1.42%
----
BHCValeant Pharmaceutic...-0.29-1.18%
Data as of 4:00pm ET, 01/25/2022

Financials

Next reporting dateFebruary 24, 2022
EPS forecast (this quarter)$0.65
Annual revenue (last year)$366.3M
Annual profit (last year)$59.9M
Net profit margin16.36%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Waltham, Massachusetts

Forecasts